Venous thromboembolism in patients with dermatomyositis and polymyositis

Clinical and Experimental Rheumatology

Volumn 29, Issue 5, 2011, Pages 846-849

  Selva O'Callaghan, A ^a   Fernandez Luque, A ^a   Martinez Gomez X ^a   Labirua Iturburu, A ^a   Vilardell Tarres M ^a  

^a Vail D'Hebron General Hospital   (Spain)

Author keywords

Cancer; Dermatomyositis; Inflammatory myopathy; Intravenous immunoglobulins; Polymyositis; Venous thromboembolism

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOTHERAPY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POLYMYOSITIS; PRIORITY JOURNAL; SENESCENCE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGED; COHORT STUDIES; DERMATOMYOSITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 83455173720     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. MERKEL PA, LO GH, HOLBROOK JT et al.: High incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's clinical occurrence of thrombosis (WeCLOT) study. Ann Intern Med 2005; 142:620-6. (Pubitemid 40529958)
2. WEIDNER S, HAFEZI-RACHTI S, RUPPRETCH HD: Thromboembolic events as a complication of antineutrophil cytoplasmic antibodyassociated vasculitis. Arthritis Rheum 2006; 55: 146-9. (Pubitemid 43235140)
3. STASSEN PM, DERKS RP, KALLENBERG CG, STEGEMAN CA: Venous thromboembolism in ANCA-associated vasculitis: incidence and risk factors. Rheumatology (Oxford). 2008; 47:
4. TOMASSON G, MONACH PA, MERKEL PA: Thromboembolic disease in vasculitis. Curr Opin Rheumatol 2009; 21:41-6.
5. MIEHSLER W, REINISCH W, VALIC E et ah: Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53: 542-8. (Pubitemid 38372979)
6. GAITONDE SD, BALLOU SP: Deep venous thrombosis in dermatomyositis. J Rheumatol 2008; 35: 2288.
7. BOHAN A, PETER JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
8. BOHAN A, PETER JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
9. SONTHEIMER RD: Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 1999; 11:475-82. (Pubitemid 29506173)
10. TRALLERO-Araguás E, LABRADOR-HORRILLO M, SELVA-O'CALLAGHAN A et a I.: Cancer-associated myositis and anti-pl55 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore). 2010; 89: 47-52.
11. INTERNATIONAL MYOSITIS ASSESSMENT AND CLINICAL STUDIES (IMACS) GROUP WEBSITE: Available at: https://dirapps.mehs.nih.gov/imacs/
12. ISENBERG DA, ALLEN E, FAREWELL V el al.: International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004; 43: 49-54. (Pubitemid 38088368)
13. FENDLER C, BRAUN J: Use of methotrexate in inflammatory myopathies. Clin Exp Rheumatol 2010; 28 (Suppl. 61): S164-7
14. ELM EV, ALTMAN DG, EGGER M, POCOCK SJ, GOTZSCHE PC, VANDENBROUCKE JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Ann Intern Med 2007; 147: 573-7. (Pubitemid 351664504)
15. GUUARRO MERINO R, MONTES SANTIAGO J, SAN ROMAN TERAN CM: Epidemiology of venous thromboembolic disease in Spain. Med Clin (Barc). 2008; 131 (Suppl. 2): 2-9.
16. DALAKAS MC, ILLA I, DAMBROSIA JM et al:. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993; 329: 1993-2000. (Pubitemid 24015043)
17. PARAN D, HERISHANU Y, ELKAYAM O, SHOPIN L, BEN-AMI R: Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis 2005; 16: 313-8. (Pubitemid 41008736)